Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning

P Ferdinandy, R Schulz, GF Baxter - Pharmacological reviews, 2007 - ASPET
Therapeutic strategies to protect the ischemic myocardium have been studied extensively.
Reperfusion is the definitive treatment for acute coronary syndromes, especially acute …

The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy

J Asbun, FJ Villarreal - Journal of the American College of Cardiology, 2006 - jacc.org
Diabetes has emerged as a major threat to worldwide health. The increasing incidence of
diabetes in young individuals is particularly worrisome given that the disease is likely to …

Metformin therapy and clinical uses

JHB Scarpello, HCS Howlett - Diabetes and Vascular …, 2008 - journals.sagepub.com
Metformin is now established as a first-line antidiabetic therapy for the management of type
2 diabetes. Its early use in treatment algorithms is supported by lack of weight gain, low risk …

Role of apoptosis in cardiovascular disease

Y Lee, ÅB Gustafsson - Apoptosis, 2009 - Springer
Apoptosis plays a key role in the pathogenesis in a variety of cardiovascular diseases due to
loss of terminally differentiated cardiac myocytes. Cardiac myocytes undergoing apoptosis …

Does a strict glycemic control during acute coronary syndrome play a cardioprotective effect? Pathophysiology and clinical evidence

A Caturano, R Galiero, PC Pafundi, A Cesaro… - Diabetes research and …, 2021 - Elsevier
A hyperglycemic state, also in non-diabetic subjects, may be associated with acute coronary
syndrome (ACS). Aim of this review is to describe the pathophysiologic association between …

Diabetic cardiomyopathy

O Asghar, A Al-Sunni, K Khavandi, A Khavandi… - Clinical …, 2009 - portlandpress.com
Diabetic cardiomyopathy is a distinct primary disease process, independent of coronary
artery disease, which leads to heart failure in diabetic patients. Epidemiological and clinical …

Exosomes derived from adipose tissue, bone marrow, and umbilical cord blood for cardioprotection after myocardial infarction

H Xu, Z Wang, L Liu, B Zhang… - Journal of Cellular …, 2020 - Wiley Online Library
Human mesenchymal stem cells (MSCs) have the potential for improving cardiac function
following myocardial infarction (MI). This study was performed to explore the …

Insight into the role of the PI3K/Akt pathway in ischemic injury and post-infarct left ventricular remodeling in normal and diabetic heart

B Walkowski, M Kleibert, M Majka, M Wojciechowska - Cells, 2022 - mdpi.com
Despite the significant decline in mortality, cardiovascular diseases are still the leading
cause of death worldwide. Among them, myocardial infarction (MI) seems to be the most …

Role of tight glycemic control during acute coronary syndrome on CV outcome in type 2 diabetes

FC Sasso, L Rinaldi, N Lascar… - Journal of Diabetes …, 2018 - Wiley Online Library
Both incidence and mortality of acute coronary syndrome (ACS) among diabetic patients are
much higher than those among nondiabetics. Actually, there are many studies that …

Management of cardiac fibrosis in diabetic rats; the role of peroxisome proliferator activated receptor gamma (PPAR-gamma) and calcium channel blockers (CCBs)

HE Mohamad, ME Askar, MM Hafez - Diabetology & metabolic syndrome, 2011 - Springer
Background Diabetes mellitus (DM) and hypertension (HTN) are accused of being
responsible for the development of the cardiac fibrosis due to severe cardiomyopathy …